NCT01174979View on ClinicalTrials.gov

Caroverin and Inner Ear Diseases

PHASE3SuspendedINTERVENTIONAL

Enrollment

170

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

August 31, 2015

Conditions

Tinnitus

Interventions

DRUG

Caroverin

treatment with eardrops 2 times for 48 hours

Trial Locations (1)

6800

Landeskrankenhaus Feldkirch, Feldkirch

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Phafag AG

INDUSTRY